Effects of Inspiratory Muscle Training After Covid-19 (ReCOV)
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
COVID-19 Vaccine Boosters in Patients With CKD
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
- Status
- COMPLETED
- Phase
- N/A
Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer
- Status
- UNKNOWN
- Phase
- NA
Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Impact of the COVID-19 Pandemic on the Organization of Healthcare in France
- Status
- UNKNOWN
- Phase
- N/A
Safety and Immunogenicity of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adults With Chronic Immune-Mediated Diseases
- Status
- TERMINATED
- Phase
- PHASE3
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease
- Status
- COMPLETED
- Phase
- PHASE3
Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE2
Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)
- Status
- UNKNOWN
- Phase
- PHASE2
Pulmonary Rehabilitation Post-COVID-19
- Status
- COMPLETED
- Phase
- NA
Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver Disease
- Status
- UNKNOWN
- Phase
- N/A
Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)
- Status
- COMPLETED
- Phase
- PHASE4
COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents
- Status
- COMPLETED
- Phase
- PHASE3
Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents
- Status
- COMPLETED
- Phase
- PHASE4